Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK2 | O60674 | 3/20 | 0.37 |
| ▸ | JAK1 | P23458 | 2/20 | 0.37 |
| ▸ | TYK2 | P29597 | 2/20 | 0.37 |
| ▸ | JAK3 | P52333 | 2/20 | 0.37 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.34 |
| ▸ | AXL | P30530 | 1/20 | 0.30 |
| ▸ | TYRO3 | Q06418 | 1/20 | 0.30 |
| ▸ | MERTK | Q12866 | 1/20 | 0.30 |
| ▸ | IDH1 | O75874 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31423999 | 0.90 | JAK2 (0.37) | JAK2JAK1TYK2JAK3 | |
| SCHEMBL31423903 | 0.89 | JAK2 (0.37) | JAK2JAK1TYK2JAK3LRRK2 | |
| SCHEMBL31423907 | 0.88 | JAK2 (0.37) | JAK2JAK1TYK2JAK3 | |
| SCHEMBL31423980 | 0.86 | JAK2 (0.42) | JAK2JAK1TYK2JAK3AXL | |
| SCHEMBL31423958 | 0.85 | JAK2 (0.38) | JAK2JAK1TYK2JAK3LRRK2 | |
| SCHEMBL31424015 | 0.84 | JAK2 (0.36) | JAK2JAK1TYK2JAK3 | |
| SCHEMBL31423978 | 0.83 | JAK2 (0.37) | JAK2JAK1TYK2JAK3 | |
| SCHEMBL31423967 | 0.83 | JAK2 (0.38) | JAK2JAK1TYK2JAK3 | |
| SCHEMBL31318293 | 0.83 | JAK2 (0.39) | JAK2JAK1TYK2JAK3LRRK2 | |
| SCHEMBL31423953 | 0.82 | IDH1 (0.33) | JAK2JAK3IDH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025054386-A1 | CDK2 INHIBITORS AND USES THEREOF | ODYSSEY THERAPEUTICS, INC. (US) | 2025-03-13 | — | — | WO | disclosed |